Outcome rate % (Target population size) | ||||||||
---|---|---|---|---|---|---|---|---|
Target Population | CCAE | MDCD | MDCR | Optum claims | Optum EHR | CUMC | AUSOM | STRIDE |
T1: Females aged 65+ with atrial fibrillation no prior stroke or anticoagulants | – | 4.95 (25,880) | 4.40 (89,156) | 4.07 (110,905) | 1.30 (149,906) | 5.75 (4312) | 2.61 (268) | 1.37 (3366) |
T2: Females with atrial fibrillation no prior stroke or anticoagulants | 1.33 (61,224) | 4.61 (33,262) | – | 3.49 (139,376) | 1.13 (189,815) | 5.00 (5758) | 1.76 (455) | 1.28 (4456) |
Sensitivity T1: Females aged 65+ with atrial fibrillation no prior stroke or anticoagulants (no anticoagulants during tar) | – | 5.04 (23,586) | 5.26 (56,511) | 4.48 (78,353) | 1.44 (99,212) | 6.23 (3403) | 4.17 (144) | 1.29 (2094) |
Sensitivity T2: Females with atrial fibrillation no prior stroke or anticoagulants (no anticoagulants during tar) | 1.28 (46,054) | 4.69 (29,546) | – | 3.73 (100,757) | 1.22 (128,409) | 5.35 (4546) | 2.73 (256) | 1.22 (2786) |